The Underwriting Challenge: Why the EBITDA You Receive Is Never the EBITDA You Should Use

Every credit memorandum starts with a headline earnings number. And in virtually every leveraged finance or private credit transaction, that number has been assembled, curated, and, in many cases, optimistically engineered by the borrower or their advisor. For lenders, the operative question is never “What does the borrower say they earn?” It is always “What do they actually, repeatably earn, and can that cash flow credibly service debt?”

The distinction between reported EBITDA, adjusted EBITDA, and normalized EBITDA sits at the very center of credit risk. Reported EBITDA is simply the GAAP earnings figure before adding back interest, taxes, depreciation, and amortization. Adjusted EBITDA is management’s first pass at add-backs, removing what they characterize as non-recurring or non-operational costs. Normalized EBITDA, by contrast, is the figure a lender independently arrives at after testing every adjustment for evidence, repeatability, and operational integrity.

These three numbers are rarely identical. In practice, due diligence teams regularly find a 20% to 40% discrepancy between a seller’s initial marketing EBITDA and the sustainable earnings that survive independent verification. At a 5x leverage multiple on a $10M credit, a $2M EBITDA haircut is a $10M structural error: one that erodes debt service coverage, violates financial covenants, and creates impairment risk from day one.

This article provides the analytical framework, step-by-step methodology, and red-flag checklist that experienced credit underwriters use to independently assess and defend a normalized EBITDA figure, before the first dollar is committed.

The Analytical Framework: Building a Lender-Defensible EBITDA Bridge

A rigorous EBITDA normalization process is not a mechanical accounting exercise; it is an independent reconstruction of a company’s sustainable operating earnings. Lenders treat seller-provided schedules as a starting point, not a conclusion; the underwriter’s job is to stress-test every line in the bridge.

The Four-Layer EBITDA Bridge

A sound underwriting methodology works through four sequential layers, each applied with increasing scrutiny:

1. Layer 1, Reported EBITDA: Begin with audited or reviewed financial statements, never tax returns or internal management accounts. The starting point must be GAAP-compliant and third-party verified. Apply this to three full trailing fiscal years plus the most recent trailing twelve months (TTM).
2. Layer 2, Standard Add-Backs (Non-Cash Items): Reinstate depreciation, amortization, stock-based compensation, and other non-cash charges. These are universally accepted and rarely contested, but lenders should confirm that D&A treatment is consistent across periods and not being manipulated to smooth earnings.
3. Layer 3, Non-Recurring and Extraordinary Item Adjustments: This is where the real work begins. Common categories include: one-time litigation settlements, M&A transaction fees, restructuring charges, facility relocation costs, one-time write-downs, and COVID-era disruptions. The lender’s task is to demand documentary support (invoices, legal agreements, board minutes) for every claimed non-recurring item. Any expense that appears in multiple years fails the non-recurring test by definition.
4. Layer 4, Pro Forma and Run-Rate Adjustments: The most contested layer. Borrowers frequently include cost synergies not yet realized, management compensation normalization, revenue from recently signed contracts not yet in-period, and EBITDA contributions from recently acquired entities. Lenders should apply a high evidentiary standard: adjustments must be already realized or supported by binding agreements, not speculative projections.

Working Example: $10M EBITDA Manufacturing Company

Consider a middle-market industrial manufacturer presenting $10.2M in adjusted EBITDA to support a $45M leveraged buyout with $30M in senior secured debt (3.0x leverage).

The Analysis: Connecting Normalized EBITDA to Credit Metrics

Once a defensible normalized EBITDA is established, underwriters must translate that figure into the core credit metrics that govern deal structure, covenant thresholds, and stress capacity.

Core Credit Metrics: Definitions and Thresholds

• Total Leverage (Debt / Normalized EBITDA): The primary sizing metric. Middle-market direct lenders typically cap senior leverage at 3.5x–4.5x depending on sector, cashflow predictability, and asset coverage. Cyclical or capital-intensive businesses merit tighter caps.
• Interest Coverage (Normalized EBITDA / Cash Interest Expense): Measures the cushion against a debt service failure. Institutional lenders generally require a minimum of 2.0x on a trailing basis; 1.5x is often the covenant trigger level. In floating-rate environments, underwriters should stress-test coverage at base rate + 200bps to model a rate shock scenario.
• Debt Service Coverage Ratio (DSCR): (Normalized EBITDA – CapEx – Taxes – Working Capital) / (Cash Interest + Amortization). A DSCR below 1.1x signals acute refinancing risk. For acquisition financing, many lenders require a DSCR of at least 1.25x at close.
• Fixed Charge Coverage Ratio (FCCR): Broader than DSCR, FCCR incorporates all fixed obligations including operating leases, mandatory debt amortization, and scheduled capex. A covenant-level FCCR of 1.10x–1.20x is standard in middle-market credit agreements.

Stress Scenario: 20% EBITDA Haircut

Applying a standard recession-scenario 20% EBITDA stress to the normalized figure of $8.4M in our example reduces earnings to $6.7M. At that level, a $30M debt load at 7.5% all-in rate produces approximately $2.25M in annual interest, consuming nearly 34% of stressed EBITDA in interest alone: before CapEx, taxes, and amortization. This stress test transforms what looked like an acceptable credit at close into a covenant-breach candidate within 18 months of an economic downturn.

Industry Standards: What Institutional Lenders Look For, And What the Data Shows

Institutional credit practitioners have sharpened their normalization standards significantly in the post-2022 rate environment. Several converging forces explain the tightening:

• Lenders are independently validating every add-back. Lenders commonly apply caps on pro forma cost savings and synergy add-backs, typically no more than 15–25% of trailing EBITDA, and resist any adjustment that cannot be documented to the general ledger, payroll system, or binding contract. Adjustments must be evidence-based and tied to invoices, payroll records, and contracts; hypothetical cost cuts or best-case outcomes are routinely rejected.
• “Recurring one-time” items are a systemic red flag. When similar restructuring charges, legal costs, or personnel expenses appear across two or more fiscal years in a seller’s schedule, they fail the non-recurring test. A sound underwriting rule: any expense appearing in 3 of 5 years is an operating cost, not an add-back.
• LPs and regulators are demanding greater transparency. Limited partners at private equity and private credit funds are demanding further transparency, and lenders are tightening underwriting standards in response. The gap between marketing EBITDA and lender-accepted EBITDA has become a formal risk factor in credit committee discussions at institutional shops.

Credit Performance Data: What Happens When EBITDA Is Misjudged

Common Mistakes in Lender EBITDA Analysis

• Accepting management-presented schedules without mapping every add-back to the general ledger
• Applying synergy add-backs before operational integration is confirmed with binding evidence
• Failing to stress-test interest coverage at current floating-rate levels plus a shock scenario
• Ignoring working capital seasonality, which can distort TTM EBITDA in capital-light businesses
• Treating owner compensation normalization as a simple market-rate substitution without accounting for replacement hire cost, transition risk, and key-man dependency

The EBITDA Normalization Underwriting Checklist

Use this step-by-step diligence framework before finalizing any EBITDA-based credit metric in a deal memo or credit committee presentation.